Tubulointerstitial renal disease

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 3, 2001, Pages 303-313

  Harris, David C H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

HUMANS; NEPHRITIS, INTERSTITIAL;

EID: 0035013380     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200105000-00003     Document Type: Review

References (92)

1. Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis
2. Course of renal injury in the Mpv 17-deficient transgenic mouse
3. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis
4. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome
5. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: A histopathological study in rat models and human glomerulopathies
6. Progressive renal disease: Does the quality of the proteinuria matter or only the quantity?
7. Cytokine gene expression in adriamycin nephropathy: Effects of antioxidant nuclear factor κB inhibitors in established disease
8. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome
9. The local production of complement in the pathogenesis of renal inflammation
10. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor
11. Complement activation products in the urine from proteinuric patients
12. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria
13. CD59 protects rat kidney from complement mediated injury in collaboration with Crry
14. C5b-9 mediates cortical interstitial disease in tubular expression of relA in proteinuric rats
15. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome
16. Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult
17. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency
18. Ischaemic acute renal failure: Long-term history of cell and matrix changes in the rat
19. Oxidant stress in hyperlipidemia-induced renal damage
20. Role of apoptosis in pathogenesis and progression of renal diseases
21. Apoptotic regulatory proteins in renal injury
22. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism
23. Mechanism of chronic obstructive uropathy: Increased expression of apoptosis promoting molecules
24. Induction of CD14 in tubular epithelial cells during kidney disease
25. Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria
26. Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis
27. Cyclin kinase inhibitor p21 CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction
28. G1 kinases and transforming growth factor-β signalling are associated with a growth pattern switch in diabetes-induced renal growth
29. Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice
30. Modification of the epidermal growth factor response by ammonia in renal cell hypertrophy
31. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies
32. Chemokine blockade as a therapy for renal disease
33. Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression
34. Chemokines and renal inflammation
35. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
36. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy
37. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
38. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
39. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
40. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats
41. Angiotensinogen and AT, antisense inhibition of osteopontin translation in rat proximal tubular cells
42. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis
43. Expression of macrophage migration inhibitory factor in human glomerulonephritis
44. Immunological function of tubular epithelial cells: The functional implications of CD40 expression
45. Functional properties of CD40-stimulation of proximal tubular epithelial cells
46. CD40/CD154 engagement stimulated MCP-1 expression and activates ERK 1/2 in human renal proximal tubule cells (PTC)
47. Central role for interferon-γ receptor in the regulation of renal MHC expression
48. CTLA41g gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft
49. Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides
50. Functional relevance of activated β1 integrins in mercury-induced nephritis
51. Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: The pathogenic role of ICAM-1 and VCAM-1
52. T lymphocyte adhesion mechanisms within inflamed human kidney
53. The proinflammatory role of hyaluronan - CD44 interactions in renal injury
54. Progressive nephropathy in mice: Sequence of histological and immunohistochemical events
55. Role of CD4+ T lymphocytes in progressive murine nephropathy
56. Role of CDS+ T lymphocytes in progressive murine nephropathy
57. Factors produced by activated leukocytes alter renal epithelial cell differentiation
58. Effects of pentoxifylline, pentifyline and γ-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
59. Interferon-γ inhibits experimental renal fibrosis
60. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
61. Transforming growth factor-β, antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
62. Connective tissue growth factor: Just another factor in renal fibrosis?
63. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
64. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation
65. Expression of decorin, biglycan, and collagen type 1 in human renal fibrosing disease
66. Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in mice
67. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
68. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction
69. Bone morphogenic protein-7 (Bmp-7) reduces chronic progressive renal injury in 5/6 nephrectomized rats
70. Effects of BMP-7 on interstitial fibrosis in rats with overload proteinuria
71. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats
72. Evidence for a progressive decline in tubulo-interstitial oxygenation in a model of rapidly progressive glomerulonephritis: Further support for the chronic hypoxia hypothesis
73. Fibrosis and angiogenesis
74. Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells
75. Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemic-reperfusion injury
76. Vascular endothelial cell growth factor (VEGF) preserves renal function and reduces fibrosis in the 5/6 remnant kidney model
77. Remodelling of the cortical peritubular microcirculation after subtotal nephrectomy in mice: Possible role in development of renal lesions
78. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy
79. PAI-1 deficiency attenuates renal interstitial fibrosis in mice with obstructive uropathy
80. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis
81. ACE inhibitors and AT1 receptor antagonists - Beyond the haemodynamic effect
82. Vasoactive factors and tubulointerstitial injury
83. In vivo administration of a nuclear transcription factor-κB decoy suppresses experimental crescentic glomerulonephritis
84. Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats
85. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney
86. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro
87. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
88. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure and cholesterol-lowering effects
89. Molecular cloning, expression and chromosomal localisation of a human tubulointerstitial nephritic antigen
90. Epstein-Barr virus infection of renal proximal tubule cells: Possible role in chronic interstitial nephritis
91. Leptospira outer membrane protein activates NFκ-B and downstream genes expressed in medullary thick ascending limb cells
92. Renal epithelium is a previously unrecognised site of HIV infection